Search

everythinglearnresearchcommunity

for

Search:↓

Thicker hair grows faster; hair loss patients have slower growth.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

Hair removal cream effectively and painlessly treated infants with hair tourniquet syndrome.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

High-frequency ultrasound can effectively visualize and assess hair loss.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

RF-based therapies might help treat hair loss.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

The conclusion is that a combination of noninvasive treatments and lifestyle changes can improve skin health during menopause.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.